Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.
Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...
Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing ...
Mumbai: Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a ...
PEGylation and glycosylation as bioconjugation tools for drug development: New webinar tackles complex chemistry for targeted ...
A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...
Nearly two dozen antibody drug conjugates (ADCs) have now been approved worldwide and revenues were already well into the ...
The intriguing startup NextSilicon, which has generated attention in HPC and other advanced computing markets since its ...
Eli Lilly (NYSE: LLY) is part of this group. On Sept. 16, the drugmaker announced plans to build a $5 billion facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback